Aeternum Health Completes Transformative Merger, Pivots Business, and Issues Highly Dilutive Equity
AETN has more than doubled off its 52-week low of $0.015 on light trading volume (0.4× avg).
Summary
Aeternum Health completed a merger, pivoting its business to critical minerals and longevity healthcare, while issuing highly dilutive equity to its new CEO who now holds significant control.
Key Events · M&A and Partnerships · AETN
-
Merger Consummated & Business Pivot
The merger of Aeternum Health LLC into Shorepower Technologies, Inc. (now Aeternum Health, Inc.) was completed on June 30, 2026. The company is shifting its focus from transportation electrification to mining critical minerals and developing longevity-focused healthcare products.
-
Change of Control & Leadership
Paul Mann, the Manager of Aeternum Health LLC, became the new President, CEO, and sole Director. Former President and CEO Jeff Kim resigned. Paul Mann's related party advances to Aeternum Health LLC totaled $1,498,000 prior to the merger.
-
Significant Equity Issuance & Dilution
Paul Mann received 49,000,000 common shares (51% ownership) and 2,000,000 Series B preferred shares (each with 40 common stock votes). The common shares issued were valued at $4,900,000, representing substantial dilution for existing shareholders. Former CEO Jeff Kim agreed to cancel up to 13,000,000 common shares.
-
Cash Injection & Going Concern
Aeternum Health LLC contributed assets including at least $1.5 million, with a minimum of $300,000 in cash, to the combined entity. The company continues to carry a 'going concern' warning, with a pro forma accumulated deficit of $(8,388,144).
Analysis · AETN · Manufacturing
Aeternum Health, Inc. (formerly Shorepower Technologies, Inc.) has completed a merger with Aeternum Health LLC, fundamentally changing its business and ownership structure. The company is pivoting from transportation electrification to focus on mining critical minerals and developing longevity-focused healthcare products. This merger, while providing a significant cash injection of at least $1.5 million to a company previously facing a going concern warning, involved the issuance of 49 million common shares and 2 million Series B preferred shares (with super-voting rights) to Paul Mann, the new President, CEO, and sole Director. This equity issuance, valued at $4.9 million for the common shares alone, represents substantial dilution for existing shareholders and concentrates control in the new leadership. Former CEO Jeff Kim also agreed to cancel 13 million shares. The company's authorized shares were increased from 100 million to 250 million, indicating significant potential for further dilution.
At the time of this filing, AETN was trading at $0.10 on OTC in the Manufacturing sector, with a market capitalization of approximately $5.2M. The 52-week trading range was $0.02 to $0.24. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.